Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The financial cost of optimising blood pressure control

A Corrigendum to this article was published on 22 September 2005

Abstract

We have investigated the financial costs of attempts to optimise blood pressure control in patients referred to our blood pressure clinic. At first referral, the average blood pressure in the 262 patients studied were 167/97 mmHg and the monthly costs of the antihypertensive drugs was £23.44. After 1 year of clinic attendance, the blood pressure was reduced to 149/87 mmHg, and the average drug costs had risen to £30.68. For drug expenditure alone, the cost of reducing systolic blood pressure by 1 mmHg was £0.36p (Euro 0.55, USD 0.55) and for diastolic blood pressure the cost-was £0.72p (Euro 1.12, USD 1.13).

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Colhoun HM, Dong W, Poulter NR . Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747–752.

    Article  CAS  Google Scholar 

  2. Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.

    Article  CAS  Google Scholar 

  3. Sever PS et al. Management guidelines in essential hypertension: report of the Second working party of the British Hypertension Society. BMJ 1993; 306: 983–987.

    Article  CAS  Google Scholar 

  4. Ramsay LE et al. British Hypertension Society Guidelines for hypertension management 1999—summary. BMJ 1999; 319: 630–635.

    Article  CAS  Google Scholar 

  5. Ramsay LE et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569–592.

    Article  CAS  Google Scholar 

  6. Bakris GL et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646–661.

    Article  CAS  Google Scholar 

  7. Lip GYH, Beevers M, Beevers DG . The Birmingham Hypertension Square for the optimum choice of add-in drugs in the management of resitant hypertension. J Hum Hypertens 1998; 12: 761–763.

    Article  CAS  Google Scholar 

  8. Kawachi I, Malcolm LA . The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal. J Hypertens 1991; 9: 199–208.

    Article  CAS  Google Scholar 

  9. Osbourne VL, Beevers DG . A comparison of hospital and general practice blood pressure readings using a shared-care record card. J Roy Coll Gen Pract 1981; 31: 345–350.

    CAS  Google Scholar 

  10. Du X et al. Case–control study of stroke and the quality of hypertension control in North West England. BMJ 1997; 314: 272–276.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D G Beevers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shiner, T., Simons, L., Parkinson, H. et al. The financial cost of optimising blood pressure control. J Hum Hypertens 19, 83–84 (2005). https://doi.org/10.1038/sj.jhh.1001778

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001778

Keywords

This article is cited by

Search

Quick links